0001209191-20-031792.txt : 20200522 0001209191-20-031792.hdr.sgml : 20200522 20200522170012 ACCESSION NUMBER: 0001209191-20-031792 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200521 FILED AS OF DATE: 20200522 DATE AS OF CHANGE: 20200522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HALE DAVID F CENTRAL INDEX KEY: 0001024004 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 20906751 MAIL ADDRESS: STREET 1: 1042-B NORTH EL CAMINO REAL, SUITE 430 CITY: ENCINITAS STATE: CA ZIP: 92024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-21 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001024004 HALE DAVID F 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2020-05-21 4 P 0 17412 A 716818 I By Hale BioPharma Ventures LLC Common Stock 18346 I By Hale Trading Company Warrants 2.51 2020-05-21 4 P 0 8706 A 2025-11-21 Common Stock 8706 8706 I By Hale BioPharma Ventures LLC Pursuant to the Securities Purchase Agreement, dated as of May 19, 2020, by and among the Issuer and the several purchasers party thereto, on May 21, 2020 the Reporting Person purchased the securities reported herein for aggregate consideration $44,792.37. The warrants are currently exercisable. /s/ Hazel M. Aker, Attorney-in-fact 2020-05-22